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Higher body mass index is associated with more
adverse changes in calf muscle characteristics in
peripheral arterial disease
Zankhana Raval, MD,a Kiang Liu, PhD,b Lu Tian, ScD,c Luigi Ferrucci, MD, PhD,d
Jack M. Guralnik, MD, PhD,e Yihua Liao, MS,b Michael H. Criqui, MD, MPH,f and
Mary M. McDermott, MD,a,b Chicago, Ill; Palo Alto and San Diego, Calif; and Baltimore, Md
Objective: This study investigated whether higher body mass index (BMI) is associated with more adverse lower extremity
muscle characteristics at baseline and more adverse changes in muscle over time among participants with lower extremity
peripheral arterial disease (PAD).
Methods: This was a longitudinal, observational study of 425 men and women with PAD and 261 without PAD.
Computed tomography was used to measure calf muscle characteristics at baseline and every 2 years. Knee extension
isometric strength, power, and 6-minute walk distance were measured at baseline and annually. Baseline BMI (kg/m2)
categories were ideal (20-25), overweight (>25-30), and obese (>30). Analyses adjust for age, race, sex, ankle brachial
index, comorbidities, and other covariates.
Results: At baseline, higher BMI among participants with PAD was associated with greater calf muscle area (ideal BMI:
5181 mm2; overweight: 5513 mm2; obese: 5695 mm2; P .0009 for trend), higher calf muscle percentage of fat (6.38%,
10.28%, 17.44%, respectively, P< .0001 for trend), lower calf muscle density (P< .0001 for trend), and higher isometric
knee extension strength (P  .015 for trend). Among participants with PAD, higher BMI was associated with greater
declines in calf muscle area (P .030 for trend) and greater increases in calf muscle percentage of fat (P .023 for trend).
Among participants without PAD, there were no significant associations of baseline BMI with changes in lower extremity
muscle outcomes over time.
Conclusions:Among PADparticipants, higher BMI is associated with greater calf muscle area at baseline. However, higher
BMI is associated with more adverse calf muscle density and calf muscle percentage of fat at baseline and greater declines
in calf muscle area over time. (J Vasc Surg 2012;55:1015-24.)
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tPeripheral arterial disease (PAD) is a common, debili-
tating condition1 and is associated with functional limita-
tion and disability,2,3 for which there are few effective
treatments. Research has demonstrated that a higher body
mass index (BMI) is associated with greater functional
decline in people with PAD.4 The pathophysiologic basis of
this association is unclear. However, studies have demon-
strated that adverse calf muscle characteristics are associated
with greater functional impairment and faster functional
decline inmen andwomenwith PAD.5,6 These associations
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doi:10.1016/j.jvs.2011.10.105f higher BMI with greater functional decline in patients
ith PAD may be partly mediated by obesity-related
hanges in calf muscle composition. However, associations
f higher BMI with calf muscle characteristics have not
een reported previously in men and women with PAD.
We studied associations of baseline BMI with calf muscle
rea, calf muscle density, calf muscle percentage of fat, knee
xtension strength, and knee extension power among partic-
pants with PAD.Wehypothesized that higher BMIwould be
ssociated with more adverse lower extremity muscle charac-
eristics at baseline and more adverse changes in muscle char-
cteristics over time. To determine whether associations iden-
ified were unique to individuals with PAD, we also studied
ssociations of BMI with baseline muscle characteristics and
hanges in these characteristics over time among individuals
ithout PAD. Finally, among participants with PAD,we used
tatistical modeling to determine whether associations of
igher baseline BMI with more rapid functional decline in
AD may be mediated by higher baseline BMI with more
dverse calf muscle characteristics, knee extension isometric
trength, and knee extension power.
ETHODS
The protocol for this study was approved by the Institu-
ional Review Boards at Northwestern University Feinberg
chool of Medicine and Catholic Health Partners Hospital.
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April 20121016 Raval et alPatient identification. Participants were men and
women with and without PAD participating in theWalking
and Leg Circulation Study II (WALCS-II).5 PAD partici-
pants were consecutively identified from three noninvasive
vascular laboratories in the Chicago area.5 A small number
of PAD participants were identified from among patients in
a general medical practice found to have a low ankle-
brachial index (ABI), consistent with PAD.5
Participants without PAD were identified from among
consecutive patients with normal results on lower extremity
arterial tests in the vascular laboratory and from among
consecutive patients in the general internal medicine prac-
tice who were found to have a normal ABI.5
Data were collected between November 6, 2002, and
October 16, 2009. All participants gave written informed
consent. Participants completed a baseline visit and up to
four annual follow-up visits. Calf muscle characteristics
were measured by computed tomography (CT) at baseline
and at 2-year and 4-year follow-up assessments, and iso-
metric knee extension strength and knee extension power
were measured at baseline and at 1, 2, and 3 years.
Inclusion and exclusion criteria. Participants were
aged 59 years or older at baseline. PAD was defined as ABI
0.90.5 Absence of PAD was defined as an ABI of 0.90 to
1.30.5 Exclusion criteria for WALCS-II have been de-
scribed.5 Exclusion criteria included an ABI 1.30, be-
cause these individuals could have stiffened lower extremity
vessels, an ABI of 0.90 to 1.30 and history of lower extrem-
ity revascularization, individuals with a life expectancy12
months, to allow for adequate follow-up, those with de-
mentia, and those with a Mini-Mental Status Examination
score of 23.7 Participants who were nursing home resi-
dents, wheelchair-bound, or who had foot or leg amputa-
tions were excluded because of severely impaired function-
ing. Non–English-speaking patients were excluded because
investigators were not fluent in non-English languages.
Potential participants with BMI20 kg/m2 were excluded
because of the small number who met this criterion and
because BMI 20 kg/m2 is typically classified distinctly
from BMI 20 to 25 kg/m2.
Body mass index. Height (in meters) and weight (in
kilograms) were measured at baseline. Weight was remea-
sured at follow-up visits. BMI was calculated as kg/m2.
BMI categories (kg/m2) were defined as ideal (20-25),
overweight (25-30), and obese (30).
Ankle brachial index. After participants rested supine
for 5 minutes, systolic pressures were measured using a
hand-held Doppler probe (Nicolet Vascular Pocket Dop
II, Golden, Colo) in the brachial, dorsalis pedis, and
posterior tibial arteries of the right and left extremities.
All pressures were measured twice. The ABI was calcu-
lated for each leg by dividing the average of the dorsalis
pedis and posterior tibial artery pressures in each leg by
the average of the four (ie, left and right) brachial
pressures.5 When one brachial pressure was higher than
the opposite arm for both measurement sets, and the two
brachial pressures differed by10 mmHg in at least one
measurement set, the arm with highest pressure was used sn the denominator for calculating the ABI for the left
nd right legs because subclavian stenosis was potentially
resent in these instances.8 The same denominator was
sed for calculating the ABI in the left and right legs.
owest leg ABI was included in analysis. Calf muscle
haracteristics were evaluated in the leg with lowest
aseline ABI.
Calf muscle characteristics. Calf muscle characteris-
ics were obtained using a CT scanner (LightSpeed;
eneral Electric Medical Systems, Waukesha, Wisc).
ross-
ectional images of the calves were obtained at 66.7% of
he distance from the distal to the proximal tibia.5 The
uscle outline was traced manually on the cross-sec-
ional CT images, excluding subcutaneous fat and bone,
sing BonAlyse software (BonAlyse OY, Jyvaskyla, Fin-
and).5,6 BonAlyse software quantifies muscle area by
umming voxels corresponding to muscle (9-271 mg/
m3) and excluding voxels corresponding to fat (270
o 8 mg/cm3).5,6 Previous cadaveric studies have shown
hat estimates of muscle area using this method were
ighly correlated with direct anatomic measurements.9
ntramuscular fat was quantified by summing voxels
orresponding to fat within the demarcated muscle com-
artment. Muscle density is a measure of muscle quality
nd was calculated as the mean number of voxels within
he range corresponding to muscle (9-271 mg/cm3) per
olume.
Isometric knee extension strength. Isometric knee
xtension strength was recorded using a computer-
inked strength chair fitted with leg attachments and
ransducers to measure isometric knee extension over 5
econds (Good Strength Chair; Metitur Oy, Jyvasklya,
inland).10 Participants were instructed to build to their
aximum strength over 2 seconds and maintain maxi-
um strength for the final 3 seconds of the test. Maxi-
um strength from two trials was used in analyses.10
Knee extension power. Knee extension power was
btained by asking subjects to push a footplate con-
ected to a flywheel using maximal effort.11 Final fly-
heel velocity was recorded by an optoswitch attached
o a microcomputer and used to calculate knee extension
ower in Watts.11 Five to nine trials were performed for
ach subject. Testing was stopped when the two highest
ower measurements were within 5% or when the partic-
pant had completed nine tests.11
Functional outcomes. Functional outcomes were
easured using a standardized protocol at baseline and
t each annual follow-up visit. The 6-minute walk dis-
ance (6MWD) was performed using standard meth-
ds.2,3,5,6 The participant walked back and forth along a
00-foot hallway, after instructions to cover as much
istance as possible.2,3 The 4-meter walking velocity was
ecorded as walking velocity over 4 meters at “usual” and
fastest” walking speeds, respectively. The faster of two
alks at each pace was included in analyses.2,3,5,6,12
Repeat chair rise was the time required for five con-
ecutive rises from a seated position in a straight-backed
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Volume 55, Number 4 Raval et al 1017chair with arms folded across the chest.12 Standing bal-
ance was recorded as the ability to perform three increas-
ingly difficult standing positions for 10 seconds each, as
previously described.12
The Short Physical Performance Battery (SPPB), with a
score range of 0 to 12, was recorded as the sum of three
separate scores (ranging, 0-4), assigned for performance in
repeated chair rises, standing balance, and usual-paced
4-meter walking velocity. A score of 0 was assigned for any
task a participant was unable to complete. Remaining
scores for each task were based on quartiles of performance
from 6,000 participants in the Established Populations
for the Epidemiologic Study for the Elderly.12
Comorbidities. Comorbidities assessed were hyper-
tension, diabetes mellitus, angina, myocardial infarction,
stroke, heart failure, pulmonary disease, cancer, spinal
stenosis, disk disease, and knee and hip osteoarthritis.
Most comorbidities were documented using algorithms
developed for the Women’s Health and Aging Study and
the Cardiovascular Health Study.13 These comorbidity
algorithms combined data from patient report, physical
examination, medical record review, medications, labo-
ratory values, and a primary care physician questionnaire.
History of hypertension was based on a physician’s indi-
cation of hypertension on the primary care physician
questionnaire or patient report of physician-diagnosed
hypertension. American College of Rheumatology crite-
ria were used to identify knee and hip osteoarthritis.14,15
Other measures. Cigarette smoking was assessed by
patient report. Activity level was by patient report of
number of blocks walked. Occurrence of lower extremity
revascularization, knee replacement surgery, or hip re-
placement surgery were measured during follow-up
based on patient-report, medical record review, and a
primary care physician questionnaire. If any of these
sources reported hip or knee replacement surgery, the
participant was considered to have had the procedure.
Patient report of lower extremity revascularization re-
quired confirmation with medical record review or a
primary care physician questionnaire.
Statistical analyses. Baseline characteristics of par-
ticipants with and without PAD across the defined BMI
categories were compared using 2 tests for categoric
variables and general linear models for continuous vari-
ables. Among participants with and without PAD, re-
spectively, analyses of covariance and statistical tests for
trend were used to compare each baseline calf muscle
characteristic, baseline knee extension strength, and
baseline knee extension power across BMI categories,
adjusting for age, race, sex, ABI (PAD participants only),
smoking, physical activity, and comorbidities. We ad-
justed for tibia length in analyses of calf muscle area and
knee extension measures.16
Associations of baseline BMI categories with average
annual change in functional performance, calf muscle
characteristics, knee extension strength, and knee exten-
sion power were analyzed using mixed-effects models, in
which a subject-specific random effect was used to ac- pount for the potential correlations among successive
nnual differences in each outcome measure. Dependent
ariables in each mixed-effect regression analysis were
he successive annual changes in functional performance
nd muscle outcomes, respectively. Analyses adjusted for
ge, race, sex, ABI (PAD participants only), smoking,
omorbidities, activity level, tibia length (muscle area
nd knee extension measures only), lower extremity
evascularization during follow-up, hip or knee replace-
ent during follow-up, and prior year functional perfor-
ance (for functional outcomes) or prior year muscle
easure (for muscle outcomes).
Among participants with PAD, adjusted analyses of
ssociations of baseline BMI with average annual func-
ional decline were repeated with additional adjustments
or baseline calf muscle percentage of fat, baseline calf
uscle density, changes in calf muscle area, change in
alf muscle percentage of fat, and all of these calf muscle
easures simultaneously. These additional analyses were
erformed to determine whether associations of BMI
ith decline in functional performance were mediated by
hese muscle characteristics. In longitudinal analyses,
MI was a time-dependent variable, in which the BMI
alue used in analyses was updated for each follow-up
isit. Statistical analyses were performed using SAS 9.2
oftware (SAS Institute Inc, Cary, NC).
ESULTS
Of 742 WALCS-II participants who completed base-
ine testing, 463 were PAD participants and 279 were
on-PAD participants. The baseline analysis included
25 PAD subjects and 261 non-PAD subjects who met
nclusion criteria (Fig 1). Of these, 357 with PAD and
29 without PAD were eligible for longitudinal analyses
Fig 1). Mean follow-up was 3.94 years.
Among the 425 PAD subjects who completed base-
ine testing, the average age was 74.9  8.2 years, the
ean ABI was 0.63  0.15, and 104 (24%) had classic
ymptoms of intermittent claudication. Among the 261
articipants without PAD who completed baseline test-
ng, the average age was 71.5  7.5 years and the mean
BI was 1.09  0.09. Among participants with PAD,
7.2% were taking a cholesterol-lowering medication
nd 6% were taking cilostazol at baseline. Among partic-
pants without PAD, 30.7% were taking a cholesterol-
owering medication. Table I shows patient characteris-
ics according to baseline BMI among participants with
nd without PAD. Higher BMI was associated with a
igher prevalence of diabetes mellitus, greater calf mus-
le area, higher calf muscle percentage of fat, and lower
alf muscle density among all participants. Among par-
icipants with PAD, higher BMI was also associated with
ounger age, higher isometric knee extension strength,
nd higher knee extension power. Among participants
ithout PAD, higher BMI values were associated with
frican American race, lower ABI values, and a higher
revalence of knee osteoarthritis (Table I).
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April 20121018 Raval et alFig 2 shows associations of baseline BMI with base-
line calf muscle characteristics and knee extension
strength among participants with PAD, adjusting for
age, race, sex, ABI, smoking, comorbidities, physical
Fig 1. Flow chart shows participants with and withou
Circulation Study II (WALCS II). BMI, Body mass inde
Table I. Baseline characteristics of 686 participants with a
baseline body mass index (BMI)
Variablea
Participants with PAD by BMI
20-25 25-30 30
(n  108) (n  184) (n  1
Age, years 76.4 (8.9) 75.2 (8.6) 73.3 (6
Black race 17.6 11.4 22.
Male sex 43.5 63.0 54.
Ankle brachial index 0.61 (0.15) 0.64 (0.15) 0.64 (0
Diabetes mellitus 23.2 30.4 46.
Angina 30.2 39.0 36.
Myocardial infarction 25.0 22.9 32.
Stroke 25.9 19.6 22.
Heart failure 25.9 28.3 34.
Osteoarthritis
Knee 13.0 9.2 17.
Hip 4.6 0.00 7.
Calf muscle
Area, mm2 4928 (901) 5649 (1388) 5742 (1
Density, gm/cm3 33.4 (3.6) 33.2 (3.8) 30.9 (4
Percentage of fat, % 7.1 (7.0) 9.9 (10.6) 17.3 (1
Isometric knee extension
strength, N 237 (85) 286 (112) 297 (1
Knee extension power, W 81 (41) 95 (50) 103 (6
aContinuous variables are presented as mean (standard deviation) and categactivity, and tibia length (muscle area and knee extension ceasures only). Higher baseline BMI was associated
ignificantly with higher calf muscle area and higher
sometric knee extension strength and was also associ-
ted with higher calf muscle percentage of fat and lower
pheral arterial disease (PAD) in the Walking and Leg
ithout peripheral arterial disease (PAD) according to
2)
Participants without PAD by BMI
(kg/m2)
P 20-25 25-30 30 P
(trend) (n  61) (n  95) (n  105) (trend)
.003 72.9 (8.2) 71.5 (6.8) 70.6 (7.6) .056
.232 8.2 23.2 23.8 .027
.147 34.4 49.5 43.8 .355
.202 1.12 (0.09) 1.10 (0.09) 1.06 (0.10) .001
.001 13.1 15.8 36.2 .001
.368 15.00 17.89 24.27 .134
.169 14.8 11.6 18.1 .446
.583 9.84 9.47 6.67 .440
.135 11.5 13.7 16.2 .393
.260 14.8 13.7 26.7 .035
.156 0.00 4.2 5.7 .089
.0001 5350 (1168) 5806 (1530) 6603 (1567) .0001
.0001 34.9 (3.8) 34.1 (3.6) 32.5 (4.1) .0001
.0001 6.9 (9.9) 9.5 (12.0) 12.2 (12.8) .005
.001 268 (97) 298 (133) 298 (109) .177
.002 104 (44) 128 (70) 115 (58) .481
ariables as percentage.t perind w
(kg/m
33)
.7)
6
1
.16)
6
4
3
6
6
3
5
687)
.5)
7.5)
18)
0)alf muscle density.
l
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i
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Volume 55, Number 4 Raval et al 1019Fig 3 shows associations of BMI with average annual
changes in lower extremity muscle characteristics, ad-
justing for age, race, sex, ABI, smoking, comorbidities,
activity level, lower extremity revascularization during
Fig 2. Adjusted associations of baseline body mass in
425 men and women with peripheral arterial disease (P
index, smoking, comorbidities, activity level, and tibi
BMI categories (kg/m2) were defined as ideal (20-2
pair-wise comparison with obese BMI category. Pair-w
.0009 (muscle area), P  .014 (isometric knee extens
for muscle area, percentage of fat, and muscle density a
leg power analysis.
Fig 3. Adjusted associations of body mass index (
participants with peripheral arterial disease. **Data are
comorbidities, activity level, tibia length (muscle area
larization during follow-up, hip or knee replacement d
categories (in kg/m2) were defined as ideal (20-25)
different value compared with the obese BMI category
between ideal BMI and obese. The pairwise P  .025
For calf muscle percentage of fat, the pairwise P  .026
291 for muscle area, percentage fat, muscle density ana
power analysis.follow-up, hip or knee replacement surgery during fol- iow-up, tibia length (muscle area and knee extension
easures only), and prior year muscle measurements.
igher baseline BMI was associated with greater decline
n calf muscle area (P  .030 for trend) and greater
BMI) with baseline calf muscle characteristics among
. **Data are adjusted for age, race, sex, ankle-brachial
th (muscle area and knee extension measures only).
verweight (25-30), and obese (30). *Significant
values were .001 (percent fat, muscle density), P 
rength), P  .048 (knee extension power). N  412
es, n  313 for leg strength analysis, and n  384 for
with change in calf muscle characteristics among
sted for age, race, sex, ankle-brachial index, smoking,
eg strength measures only), lower extremity revascu-
follow-up, and prior calf muscle characteristics. BMI
rweight (25-30), and obese (30). *Significantly
muscle area, the pairwise P .043 for the comparison
the comparison between overweight BMI and obese.
the comparison between obese and overweight. N 
n 264 for leg strength analysis, and n 324 for legdex (
AD)
a leng
5), o
ise P
ion st
nalysBMI)
adju
and l
uring
, ove
. For
4 for
1 for
lyses,ncrease in calf muscle percentage of fat (P  .023 for
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April 20121020 Raval et altrend). There were no associations between higher base-
line BMI and change in calf muscle density or leg
strength measures (Fig 3).
Table II reports the associations of baseline BMI
with average annual functional decline, adjusting for age,
race, sex, ABI, smoking, comorbidities, activity level,
lower extremity revascularization during follow-up, hip
or knee replacement during follow-up, and prior year
performance. Model 1a in Table II summarizes the
associations of baseline BMI with average annual func-
tional decline among participants with baseline calf mus-
cle characteristic data. Higher baseline BMI was associ-
ated with greater declines in the SPPB (P  .025 for
trend), usual-paced walking velocity (P  .001 for
trend), fastest-paced walking velocity (P trend  .001),
and 6MWD (P  .002 for trend; Model 1a, Table II).
The significant association between higher BMI and
greater decline in the SPPB was attenuated and no longer
statistically significant after additional adjustment for
baseline calf muscle percentage of fat and baseline calf
muscle density (Table II).
Associations of higher baseline BMI with faster de-
clines in walking velocity and the 6MWDwere somewhat
attenuated but remained highly statistically significant
after additional adjustment for baseline calf muscle per-
centage of fat and baseline calf muscle density, respec-
tively (Table II). These findings suggest that more ad-
verse calf muscle percentage of fat and calf muscle
density at baseline among more obese PAD participants
may contribute to associations of higher baseline BMI
with faster decline in the SPPB but may not contribute
substantially to associations of higher baseline BMI with
faster decline in walking velocity or the 6MWD.
Model 1a was repeated among participants with
follow-up data on changes in calf muscle characteristics over
time (Table II). When the sample size was limited to
patients with follow-up calf muscle data, higher BMI was
associated significantly with greater declines in the SPPB,
the two measures of walking velocity, and the 6MWD
(Table II, Model 1b). Associations of higher BMI values
with greater declines in the SPPB and walking velocity
remained statistically significant and were attenuated only
to a small degree after adjusting for change in percentage of
fat and change in calf muscle area. Associations of BMIwith
decline in the SPPB and usual-paced walking velocity were
attenuated and no longer statistically significant after addi-
tional adjustment for baseline calf muscle measures and
changes in calf muscle measures (Table II).
However, the association of BMI with decline in
fast-paced 4-meter walking velocity and 6WMD re-
mained statistically significant after adjustment for base-
line calf muscle measures and changes in calf muscle
measures (Table II). These findings suggest that associ-
ations of higher baseline BMI with more adverse calf
muscle characteristics at baseline and changes in calf
muscle over time may contribute to faster rates of decline
in the SPPB among more obese PAD participants. cAmong participants without PAD, higher BMI was
ssociated with higher calf muscle area and lower calf
uscle density at baseline, adjusting for age, race, sex,
moking, physical activity, comorbidities, and tibia length
calf muscle area and knee extension outcome only; Table
II). Among participants without PAD, higher BMI was
ot associated with calf muscle percentage of fat or lower
xtremity strength measures after adjusting for confound-
rs (Table III). Among participants without PAD, there
ere no associations of baseline BMI with change in lower
xtremitymusclemeasures over time, adjusting for age, sex,
ace, smoking, physical activity, comorbidities, prior year
uscle measures, and hip or knee replacement during
ollow-up (Table III).
ISCUSSION
The results reported here demonstrate that higher
aseline BMI was associated with a higher baseline calf
uscle percentage of fat and lower baseline calf muscle
ensity among men and women with PAD. However,
igher baseline BMI was also associated with higher calf
uscle area and better knee extension isometric
trength. In longitudinal analyses, higher BMI at base-
ine was associated with greater decline in calf muscle
rea and greater increases in calf muscle percentage of
at, but not with significant changes in calf muscle den-
ity, knee extension isometric strength, or knee exten-
ion power compared with lower baseline BMI values.
mong participants without PAD, higher BMI was asso-
iated with greater calf muscle area and lower calf muscle
ensity at baseline. There were no associations of base-
ine BMI with change in lower extremity muscle charac-
eristics over time among participants without PAD.
The association of higher BMI with lower baseline
alf muscle density at baseline among participants with
nd without PAD and the association of higher BMI with
reater baseline calf muscle percentage of fat at baseline
mong individuals with PAD may reflect poorer muscle
uality in obese participants with and without PAD,
espite higher muscle quantity, measured by greater calf
uscle area. The associations of higher BMI with higher
alf muscle area among participants with and without
AD and the association of higher BMI with better knee
xtension strength among participants with PAD at base-
ine may reflect the need for greater muscle quantity or
trength to support heavier body weight in obese indi-
iduals. Higher muscle area may compensate for lower
uscle density (ie, poorer muscle quality) among obese
articipants.
Among participants with PAD, higher baseline BMI
as associated with greater declines in the SPPB score,
sual and fast-paced walking velocity, and 6MWD after
djusting for confounders. The association of higher BMI
ith faster decline in the SPPB was attenuated after addi-
ional adjustment for the adverse calf muscle characteristics
ssociated with higher BMI values. This finding suggests
hat adverse associations of BMI with baseline calf muscle
haracteristics and changes in these characteristics over time
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Volume 55, Number 4 Raval et al 1021Table II. Baseline body mass index (BMI) and functional decline among participants with peripheral arterial disease (PAD)
Variablea
BMI (kg/m2)
P
(trend)20-25 25-30 30
Associations of BMI with functional decline with and without additional adjustment for baseline calf muscle characteristics
Short physical performance battery decline
(n  304) (n  76) (n  138) (n  90)
Model 1a 0.32 (0.53 to 0.11) 0.35 (0.53 to 0.17) 0.57 (0.78 to 0.37) .025
Plus adjustment for baseline percent
fat 0.35 (0.57 to 0.136) 0.35 (0.54 to 0.17) 0.52 (0.732 to 0.32) .159
Plus adjustment for baseline calf
density 0.33 (0.55 to 0.117) 0.36 (0.54 to 0.17) 0.55 (0.753 to 0.34) .064
Usual walking velocity decline, m/s
(n  337) (n  81) (n  152) (n  104)
Model 1a 0.03 (0.04 to 0.01) 0.04 (0.05 to 0.02) 0.05 (0.06 to 0.04) .001
Plus adjustment for baseline percent
fat 0.03 (0.04 to 0.02) 0.04 (0.05 to 0.02) 0.05 (0.06 to 0.03) .004
Plus adjustment for baseline calf
density 0.03 (0.04 to 0.01) 0.04 (0.05 to 0.02) 0.05 (0.06 to 0.04) .002
Fastest walking velocity decline, m/s
(n  332) (n  81) (n  149) (n  102)
Model 1a 0.02 (004 to 0.01) 0.03 (0.05 to 0.01) 0.05 (0.06 to 0.03) .001
Plus adjustment for baseline percent
fat 0.02 (0.04 to 0.01) 0.03 (0.05 to 0.01) 0.05 (0.06 to 0.03) .001
Plus adjustment for baseline calf
density 0.02 (0.04 to 0.01) 0.03 (0.05 to 0.02) 0.05 (0.06 to 0.03) .001
6-minute walk distance decline, feet
(n  323) (n  80) (n  146) (n  97)
Model 1a 32.2 (57.4 to 7.1) 45.7 (66.1 to 25.3) 76.3 (101.0 to 51.7) .002
Plus adjustment for baseline percent
fat 33.2 (58.7 to 7.8) 45.6 (66.13 to 25.1) 74.9 (100.0 to 49.8) .004
Plus adjustment for baseline calf
density 32.3 (57.6 to 7.0) 45.7 (66.22 to 25.2) 76.2 (101.3 to 51.1) .002
Associations of BMI with functional decline with and without additional adjustment for changes in calf muscle characteristics
over time
Short physical performance battery decline
(n  234) (n  57) (n  109) (n  68)
Model 1b 0.74 (1.3 to 0.24) 0.86 (1.4 to 0.38) 1.1 (1.6 to 0.62) .003
Plus adjustment for change in
percentage of fat 0.75 (1.3 to 0.26) 0.86 (1.3 to 0.38) 1.1 (1.6 to 0.62) .006
Plus adjustment for change in calf area 0.77 (1.3 to 0.28) 0.86 (1.3 to 0.39) 1.1 (1.5 to 0.60) .012
Plus baseline muscle density, baseline
percent fat, change in percent fat,
change in muscle area 0.82 (1.3 to 0.32) 0.89 (1.4 to 0.41) 1.1 (1.5 to 0.58) .081
Usual walking velocity decline, m/s
(n  257) (n  60) (n  120) (n  77)
Model 1b 0.02 (0.05 to 0.02) 0.02 (0.06 to 0.01) 0.04 (0.07 to 0.00) .017
Plus adjustment for change in
percentage of fat 0.02 (0.05 to 0.02) 0.02 (0.06 to 0.01) 0.04 (0.07 to 0.00) .019
Plus adjustment for change in calf area 0.02 (0.05 to 0.02) 0.02 (0.05 to 0.01) 0.04 (0.07 to 0.00) .023
Plus baseline muscle density, baseline
percent fat, change in percent fat,
change in muscle area 0.02 (0.05 to 0.02) 0.02 (0.05 to 0.01) 0.03 (0.07 to 0.00) .061
follow-up, and prior year performance. Model 1a is limited to all participants with baseline muscle data. Model 1b is limited to participants with follow-up
muscle data.
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lower extremity muscle characteristics among participants without peripheral arterial disease (PAD)
Variable
BMI (kg/m2)
P
(trend)20-25 25-30 30
Baseline dataa
Muscle area (mm2) n  60
5401 (5070-5732)
n  92
5731 (5474-5988)
n  104
6636 (6387-6885)
.001
Percent fat n  60
8.42 (5.33-11.50)
n  93
9.34 (6.96-11.73)
n  104
11.46 (9.14-13.78)
.117
Muscle density n  60
34.5 (33.5-35.4)
n  93
34.1 (33.4-34.9)
n  104
32.8 (32.1-33.5)
.005
Isometric knee extension
strength
n  51
277 (252-301)
n  78
293 (274-312)
n  83
297 (278-316) .226
Leg power n  56
107 (94-120)
n  85
125 (115-135)
n  99
117 (107-126)
.404
Longitudinal data b
Muscle area (mm2) n  45
239 (320 to 158)
n  69
229 (291 to 168)
n  80
289 (350 to 228)
.214
Percent fat n  45
1.14 (0.47 to 1.81)
n  70
1.09 ([0.58 to 1.59)
n  80
1.48 (1.00 to 1.97)
.112
Muscle density n  45
0.70 (1.09 to 0.31)
n  70
0.32 (0.61 to 0.03)
n  80
0.65 (0.94 to 0.37)
.456
Isometric knee extension
strength
n  43
8.60 (16.70 to 0.49)
n  70
7.39 (12.98 to 1.80)
n  72
3.96 (10.46 to 2.54) .875
Leg power n  50
4.68 (9.09 to 0.27)
n  77
1.25 (4.60 to 2.11)
n  92
0.26 (3.54 to 3.03)
.388
aBaseline associations are adjusted for age, sex, race, smoking, physical activity, comorbitities (calf muscle area outcome only). Values are shown with 95%
confidence intervals.
bTable II. Continued
Variablea
BMI (kg/m2)
P
(trend)20-25 25-30 30
Fastest walking velocity decline, m/s
(n  256) (n  60) (n  119) (n  77)
Model 1b 0.03 (0.07 to 0.01) 0.05 (0.08 to 0.01) 0.05 (0.09 to 0.01) .009
Plus adjustment for change in
percentage of fat 0.03 (0.07 to 0.01) 0.04 (0.08 to 0.01) 0.05 (0.09 to 0.01) .01
Plus adjustment for change in calf area 0.03 (0.07 to 0.01) 0.04 (0.08 to 0.01) 0.05 (0.09 to 0.01) .01
Plus baseline muscle density, baseline
percent fat, change in percent fat,
change in muscle area 0.03 (0.07 to 0.01) 0.04 (0.08 to 0.00) 0.05 (0.09 to 0.01) .013
6-minute walk distance decline, ft
(n  252) (n  60) (n  116) (n  76)
Model 1b 23.5 (66.8 to 19.9) 37.8 (78.1 to 2.6) 64.7 (107.3 to 22.1) .0109
Plus adjustment for change in
percentage of fat 21.8 (64.8 to 21.3) 34.9 (75.1 to 5.3) 61.4 (103.8 to 18.9) .013
Plus adjustment for change in calf area 21.5 (64.7 to 21.7) 35.5 (75.8 to 4.8) 61.3 (103.9 to 18.6) .012
Plus baseline muscle density, baseline
percent fat, change in percent fat,
change in muscle area 24.1 (67.3 to 19.2) 35.1 (75.2 to 5.0) 60.4 (103.0 to 17.5) .037
aData shown are average annual decline in functional performance and 95% confidence intervals across baseline BMI categories. Model 1 adjusts for age, race,
sex, ankle brachial index, smoking, comorbidities, physical activity, lower extremity revascularization during follow-up, hip or knee replacement duringLongitudinal associations (i.e., average annual change in each leg muscle measure) are adjusted for age, sex, race, smoking, physical activity, comorbidities,
prior year muscle measurement, and hip or knee replacement during follow-up. Values are shown with 95% confidence intervals.
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greater declines in the SPPB. However, among participants
with PAD, associations of higher BMI with faster declines
in walking velocity and the 6MWD were not substantially
attenuated by additional adjustments for baseline adverse
muscle characteristics or changes in muscle characteristics
associated with higher BMI values. Thus, these associations
of higher BMI with faster declines in walking velocity and
the 6MWDare not likely to be explained by the associations
of higher BMI with more adverse calf muscle characteristics
at baseline or changes in these characteristics over time.
Our findings suggest, for the first time, that obesity is
associated with lower calf muscle density, higher calf muscle
percentage of fat, and greater declines in calf muscle area as
measured by CT in men and women with PAD. The combi-
nation of PAD with higher BMI values may be particularly
adverse because higher BMI values were associated with
greater declines in calf muscle area and greater increases in calf
muscle percentage of fat only among participants with PAD
but not among participants without PAD.
The significance of the faster decline in calf muscle area
among PAD participants with higher baseline BMI is unclear
because obese participants with PAD did not experience a
greater decline in knee extension strength or knee extension
power. However, our longitudinal measures of lower extrem-
ity strengthdid not include changes in plantar flexion,which is
expected to better reflect declines in calf muscle area over
time, because calf muscle is responsible for plantar flexion
strength while muscles proximal to the calf are responsible for
knee extension.
This study has some limitations:
1. The study is observational, and causal inferences cannot
be made.
2. Of the 425 eligible PAD participants who completed
baseline testing, only 357 had follow-up data for these
analyses.
3. Although our cohort was monitored prospectively for 4
years, longer follow-up may be needed to detect addi-
tional adverse changes in lower extremity muscle asso-
ciated with obesity in PAD.
4. We did not have longitudinal data on plantarflexion
strength.
5. We did not have data on insulin resistance, which may
be a mediator of the associations reported here.
6. We did not collect CT images of upper extremity muscle.
Therefore, we cannot determine whether associations of
baseline BMI with changes in lower extremity muscle
characteristics are unique to the lower extremities.
CONCLUSIONS
Higher BMI is associated withmore adverse calf muscle
density and percentage of fat at baseline and greater decline
in calf muscle area at 4-year follow-up among men and
women with PAD. Further investigation is needed to de-
termine whether weight loss among obese patients with
PAD can protect against adverse muscle characteristics at
baseline and adverse changes in calf muscle characteristics
1ver time. Our study suggests that PAD patients should be
ncouraged to maintain an ideal body weight.
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